Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment

International Journal of Cancer

Volumn 138, Issue 1, 2016, Pages 14-21

  Penfornis, Patrice ^a   Vallabhaneni, Krishna C ^a   Whitt, Jason ^a   Pochampally, Radhika ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

exosomes; extracellular vesicles; Lipids; mesenchymal stem cells; microRNA; MSCs; proteins; RNA; tumor microenvironment

Indexed keywords

ARGONAUTE 2 PROTEIN; LIPID; MICRORNA; NUCLEIC ACID; PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL COMMUNICATION; CELL ISOLATION; CELL SIZE; CELL STRUCTURE; CELL TRANSFER; CELLULAR SECRETION; EXOSOME; HUMAN; INTRACELLULAR SIGNALING; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA PROCESSING; RNA TRANSCRIPTION; RNA TRANSPORT; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL COMMUNICATION; EXTRACELLULAR VESICLES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPIDS; MESENCHYMAL STROMAL CELLS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASMS; PROTEINS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84944279491     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29417     Document Type: Article

References (133)

1. Howlett AR, Bissell MJ., The influence of tissue microenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium. Epithelial Cell Biol 1993; 2: 79-89.
2. Lee TH, D'Asti E, Magnus N, et al., Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'. Semin Immunopathol 2011; 33: 455-67.
3. Friend C, Marovitz W, Henie G, et al., Observations on cell lines derived from a patient with Hodgkin's disease. Cancer Res 1978; 38: 2581-91.
4. Harding C, Heuser J, Stahl P., Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 1983; 97: 329-39.
5. Pan BT, Teng K, Wu C, et al., Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol 1985; 101: 942-8.
6. Trams EG, Lauter CJ, Salem N Jr., et al., Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 1981; 645: 63-70.
7. Ginestra A, La Placa MD, Saladino F, et al., The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res 1998; 18: 3433-7.
8. Kim HK, Song KS, Park YS, et al,. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: Possible role of a metastasis predictor. Eur J Cancer 2003; 39: 184-91.
9. Zwicker JI, Liebman HA, Neuberg D, et al,. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009; 15: 6830-40.
10. D'Souza-Schorey C, Clancy JW,. Tumor-derived microvesicles: Shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 2012; 26: 1287-99.
11. van der Pol E, Boing AN, Harrison P, et al., Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 2012; 64: 676-705.
12. Kharaziha P, Ceder S, Li Q, Panaretakis T., Tumor cell-derived exosomes: A message in a bottle. Biochim Biophys Acta 2012; 1826: 103-11.
13. Rak J., Microparticles in cancer. Semin Thromb Hemost 2010; 36: 888-906.
14. Kandouz M, Batist G., Gap junctions and connexins as therapeutic targets in cancer. Expert Opin Ther Targets 2010; 14: 681-92.
15. Gilleron J, Carette D, Chevallier D, et al., Molecular connexin partner remodeling orchestrates connexin traffic: From physiology to pathophysiology. Crit Rev Biochem Mol Biol 2012; 47: 407-23.
16. Mroue RM, El-Sabban ME, Talhouk RS., Connexins and the gap in context. Integr Biol (Camb) 2011; 3: 255-66.
17. Tsuyada A, Chow A, Wu J, et al., CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res 2012; 72: 2768-79.
18. Allinen M, Beroukhim R, Cai L, et al., Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004; 6: 17-32.
19. Orimo A, Gupta PB, Sgroi DC, et al., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335-48.
20. Antonyak MA, Li B, Boroughs LK, et al., Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci USA 2011; 108: 4852-7.
21. Lim PK, Bliss SA, Patel SA, et al., Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res 2011; 71: 1550-60.
22. Luga V, Zhang L, Viloria-Petit AM, et al., Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration. Cell 2012; 151: 1542-56.
23. Pap E., The role of microvesicles in malignancies. Adv Exp Med Biol 2011; 714: 183-99.
24. Janowska-Wieczorek A, Marquez-Curtis LA, Wysoczynski M, et al., Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion 2006; 46: 1199-209.
25. Yang M, Chen J, Su F, et al., Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 2011; 10: 117.
26. Joyce JA, Pollard JW., Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 239-52.
27. Artacho-Cordon A, Artacho-Cordon F, Rios-Arrabal S, et al., Tumor microenvironment and breast cancer progression: A complex scenario. Cancer Biol Ther 2012; 13: 14-24.
28. Louie E, Nik S, Chen JS, et al., Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res 2010; 12: R94.
29. Kalluri R, Zeisberg M., Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
30. Cuiffo BG, Karnoub AE., Mesenchymal stem cells in tumor development: Emerging roles and concepts. Cell Adh Migr 2012; 6: 220-30.
31. Mao Y, Keller ET, Garfield DH, et al., Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev 2012; 32: 303-15.
32. Pittenger MF, Mackay AM, Beck SC, et al., Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
33. Smith JR, Pochampally R, Perry A, et al., Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells 2004; 22: 823-31.
34. Wolfe M, Pochampally R, Swaney W, et al., Isolation and culture of bone marrow-derived human multipotent stromal cells (hMSCs). Methods Mol Biol 2008; 449: 3-25.
35. Hall B, Andreeff M, Marini F., The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 2007: 263-83.
36. Prockop DJ., Repair of tissues by adult stem/progenitor cells (MSCs): Controversies, myths, and changing paradigms. Mol Ther 2009; 17: 939-46.
37. Vallabhaneni KC, Tkachuk S, Kiyan Y, et al., Urokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells. Cardiovasc Res 2011; 90: 113-21.
38. Studeny M, Marini FC, Champlin RE, et al., Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002; 62: 3603-8.
39. Reddy BY, Lim PK, Silverio K, et al., The microenvironmental effect in the progression, metastasis, and dormancy of breast cancer: A model system within bone marrow. Int J Breast Cancer 2012; 2012: 721659.
40. Birnbaum T, Roider J, Schankin CJ, et al., Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J Neurooncol 2007; 83: 241-7.
41. Dwyer RM, Potter-Beirne SM, Harrington KA, et al., Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 2007; 13: 5020-7.
42. Feng B, Chen L., Review of mesenchymal stem cells and tumors: Executioner or coconspirator? Cancer Biother Radiopharm 2009; 24: 717-21.
43. Schichor C, Birnbaum T, Etminan N, et al., Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp Neurol 2006; 199: 301-10.
44. Spaeth EL, Dembinski JL, Sasser AK, et al., Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PloS One 2009; 4: E4992.
45. Hogan NM, Dwyer RM, Joyce MR, et al., Mesenchymal stem cells in the colorectal tumor microenvironment: Recent progress and implications. Int J Cancer 2012; 131: 1-7.
46. Kidd S, Spaeth E, Klopp A, et al., The (in) auspicious role of mesenchymal stromal cells in cancer: Be it friend or foe. Cytotherapy 2008; 10: 657-67.
47. Djouad F, Plence P, Bony C, et al., Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102: 3837-44.
48. Zhu W, Xu W, Jiang R, et al., Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol 2006; 80: 267-74.
49. Sanchez CG, Penfornis P, Oskowitz AZ, et al., Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis 2011; 32: 964-72.
50. Cocucci E, Meldolesi J., Ectosomes. Curr Biol 2011; 21: R940-1.
51. Greco V, Hannus M, Eaton S., Argosomes: A potential vehicle for the spread of morphogens through epithelia. Cell 2001; 106: 633-45.
52. Gyorgy B, Szabo TG, Pasztoi M, et al., Membrane vesicles, current state-of-the-art: Emerging role of extracellular vesicles. Cell Mol Life Sci 2011; 68: 2667-88.
53. Ronquist G., Prostasomes are mediators of intercellular communication: From basic research to clinical implications. J Intern Med 2012; 271: 400-13.
54. Tauro BJ, Greening DW, Mathias RA, et al., Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 2012; 56: 293-304.
55. Mathivanan S, Ji H, Simpson RJ., Exosomes: Extracellular organelles important in intercellular communication. J Proteom 2010; 73: 1907-20.
56. Nabhan JF, Hu R, Oh RS, et al., Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc Natl Acad Sci USA 2012; 109: 4146-51.
57. van der Pol E, Hoekstra AG, Sturk A, et al., Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost 2010; 8: 2596-607.
58. Thery C, Amigorena S, Raposo G, et al., Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006;Chapter 3:Unit 3 22.
59. Vallabhaneni K PP, Dhule S, Guillonneau F, et al., Microvesicles from bone marrow mesenchymal stem/stromal cells transport tumor supportive microRNA, proteins and lipids. Oncotarget 2014; Published December 31, 2014.
60. Thery C, Ostrowski M, Segura E., Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581-93.
61. Al-Nedawi K, Meehan B, Rak J., Microvesicles: Messengers and mediators of tumor progression. Cell Cycle 2009; 8: 2014-8.
62. Simpson RJ, Lim JW, Moritz RL, et al., Exosomes: Proteomic insights and diagnostic potential. Expert Rev Proteomics 2009; 6: 267-83.
63. Booth AM, Fang Y, Fallon JK, et al., Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol 2006; 172: 923-35.
64. Lenassi M, Cagney G, Liao M, et al., HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 2010; 11: 110-22.
65. Katzmann DJ, Odorizzi G, Emr SD., Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol 2002; 3: 893-905.
66. Oksvold MP, Neurauter A, Pedersen KW., Magnetic bead-based isolation of exosomes. Methods Mol Biol 2015; 1218: 465-81.
67. Van Deun J, Mestdagh P, Sormunen R, et al., The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracellular Vesicles 2014; 3.
68. Lv LL, Cao Y, Liu D, et al., Isolation and quantification of microRNAs from urinary exosomes/microvesicles for biomarker discovery. Int J Biol Sci 2013; 9: 1021-31.
69. Rekker K, Saare M, Roost AM, et al., Comparison of serum exosome isolation methods for microRNA profiling. Clin Biochem 2014; 47: 135-8.
70. Gyorgy B, Modos K, Pallinger E, et al., Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood 2011; 117: E39-48.
71. Jeppensen DK, Hvam ML, Primdahl-Bengtson B, et al., Comparative analysis odf discrete exosome fractions obtained by differential centrifugation. J Extracellular Vesicles 2014; 3.
72. Hosseini-Beheshti E, Pham S, Adomat H, et al., Exosomes as biomarker enriched microvesicles: Characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes. Mol Cell Proteomics 2012; 11: 863-85.
73. Kesimer M, Scull M, Brighton B, et al., Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: A possible role in innate defense. FASEB J 2009; 23: 1858-68.
74. Lau CS, Wong DT., Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro. PloS One 2012; 7: E33037.
75. Connor DE, Exner T, Ma DD, et al., The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010; 103: 1044-52.
76. Shelke GV, Lasser C, Gho YS, et al,. Importance of exosome depletion protocols to eliminate functional and RNA-containing extracellular vesicles from fetal bovine serum. J Extracellular Vesicles 2014; 3.
77. Muralidharan-Chari V, Clancy JW, Sedgwick A, et al., Microvesicles: Mediators of extracellular communication during cancer progression. J Cell Sci 2010; 123: 1603-11.
78. Beloribi S, Ristorcelli E, Breuzard G, et al., Exosomal lipids impact notch signaling and induce death of human pancreatic tumoral SOJ-6 cells. PloS One 2012; 7: E47480.
79. Kosaka N, Iguchi H, Yoshioka Y, et al., Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010; 285: 17442-52.
80. Marsh M, van Meer G., Cell biology. No ESCRTs for exosomes. Science 2008; 319: 1191-2.
81. Trajkovic K, Hsu C, Chiantia S, et al., Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008; 319: 1244-7.
82. Wang G, Dinkins M, He Q, et al., Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): Potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem 2012; 287: 21384-95.
83. Mathivanan S, Fahner CJ, Reid GE, et al., ExoCarta 2012: Database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012; 40: D1241-4.
84. Kim HS, Choi DY, Yun SJ, et al., Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res 2012; 11: 839-49.
85. Khatua AK, Taylor HE, Hildreth JE, et al., Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F. Virology 2010; 400: 68-75.
86. Peters DL, Pretorius PJ., Origin, translocation and destination of extracellular occurring DNA-a new paradigm in genetic behaviour. Clin Chim Acta 2011; 412: 806-11.
87. Vickers KC, Remaley AT., Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 2012; 23: 91-7.
88. Buschow SI, van Balkom BW, Aalberts M, et al., MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol Cell Biol 2010; 88: 851-6.
89. Geminard C, De Gassart A, Blanc L, et al., Degradation of AP2 during reticulocyte maturation enhances binding of hsc70 and Alix to a common site on TFR for sorting into exosomes. Traffic 2004; 5: 181-93.
90. Rajendran L, Honsho M, Zahn TR, et al., Alzheimer's disease beta-amyloid peptides are released in association with exosomes. ProcNatl Acad Sci USA 2006; 103: 11172-7.
91. Nickel W., Unconventional secretory routes: Direct protein export across the plasma membrane of mammalian cells. Traffic 2005; 6: 607-14.
92. Bushati N, Cohen SM., microRNA functions. Annu Rev Cell Dev Biol 2007; 23: 175-205.
93. He L, Hannon GJ., MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-31.
94. Blondal T, Jensby Nielsen S, Baker A, et al., Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 2012; 59: S1-6.
95. Eldh M, Lotvall J, Malmhall C, et al., Importance of RNA isolation methods for analysis of exosomal RNA: Evaluation of different methods. Mol Immunol 2012; 50: 278-86.
96. Kosaka N, Iguchi H, Yoshioka Y, et al., Competitive interactions of cancer cells and normal cells via secretory microRNAs. J Biol Chem 2012; 287: 1397-405.
97. Zhuang G, Wu X, Jiang Z, et al., Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J 2012; 31: 3513-23.
98. Ono M, Kosaka N, Tominaga N, et al., Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Science Signal 2014; 7: Ra63.
99. Palma J, Yaddanapudi SC, Pigati L, et al., MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res 2012; 40: 9125-38.
100. Pigati L, Yaddanapudi SC, Iyengar R, et al., Selective release of microRNA species from normal and malignant mammary epithelial cells. PloS One 2010; 5: E13515.
101. Chevillet JR, Kang Q, Ruf IK, et al., Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci USA 2014; 111: 14888-93.
102. Melo SA, Sugimoto H, O'Connell JT, et al., Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis. Cancer Cell 2014; 26: 707-21.
103. Ratajczak J, Miekus K, Kucia M, et al., Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: Evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006; 20: 847-56.
104. Weber C, Schober A, Zernecke A., MicroRNAs in arterial remodelling, inflammation and atherosclerosis. Curr Drug Targets 2010; 11: 950-6.
105. Zernecke A, Bidzhekov K, Noels H, et al., Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009; 2: Ra81.
106. Koh W, Sheng CT, Tan B, et al., Analysis of deep sequencing microRNA expression profile from human embryonic stem cells derived mesenchymal stem cells reveals possible role of let-7 microRNA family in downstream targeting of hepatic nuclear factor 4 alpha. BMC Genom 2010; 11Suppl1: S6.
107. Yuan A, Farber EL, Rapoport AL, et al., Transfer of microRNAs by embryonic stem cell microvesicles. PloS One 2009; 4: E4722.
108. Gregory LA, Ricart RA, Patel SA, et al., microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis. Curr Cancer Ther Rev 2011; 7: 176-83.
109. Skog J, Wurdinger T, van Rijn S, et al., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10: 1470-6.
110. Zhang Y, Liu D, Chen X, et al., Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010; 39: 133-44.
111. Chiba M, Kimura M, Asari S., Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines. Oncol Rep 2012; 28: 1551-8.
112. Gibbings DJ, Ciaudo C, Erhardt M, et al., Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 2009; 11: 1143-9.
113. Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, et al., Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun 2013; 4: 2980.
114. van Doormaal FF, Kleinjan A, Di Nisio M, et al., Cell-derived microvesicles and cancer. Neth J Med 2009; 67: 266-73.
115. Ginestra A, Miceli D, Dolo V, et al., Membrane vesicles in ovarian cancer fluids: A new potential marker. Anticancer Res 1999; 19: 3439-45.
116. van Niel G, Porto-Carreiro I, Simoes S, et al., Exosomes: A common pathway for a specialized function. J Biochem 2006; 140: 13-21.
117. Andreola G, Rivoltini L, Castelli C, et al., Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 2002; 195: 1303-16.
118. Abid Hussein MN, Boing AN, Sturk A, et al., Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost 2007; 98: 1096-107.
119. Hotary KB, Allen ED, Brooks PC, et al., Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003; 114: 33-45.
120. Ambudkar SV, Sauna ZE, Gottesman MM, et al., A novel way to spread drug resistance in tumor cells: Functional intercellular transfer of P-glycoprotein (ABCB1). Trends Pharmacol Sci 2005; 26: 385-7.
121. Levchenko A, Mehta BM, Niu X, et al., Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. Proc Natl Acad Sci USA 2005; 102: 1933-8.
122. Castellana D, Zobairi F, Martinez MC, et al., Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: A role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res 2009; 69: 785-93.
123. Katsuda T, Kosaka N, Takeshita F, et al., The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics 2013; 13: 1637-53.
124. Lund E, Guttinger S, Calado A, et al., Nuclear export of microRNA precursors. Science 2004; 303: 95-8.
125. O'Toole AS, Miller S, Haines N, et al., Comprehensive thermodynamic analysis of 3' double-nucleotide overhangs neighboring Watson-Crick terminal base pairs. Nucleic Acids Res 2006; 34: 3338-44.
126. Guo L, Lu Z., The fate of miRNA∗ strand through evolutionary analysis: Implication for degradation as merely carrier strand or potential regulatory molecule? PloS One 2010; 5: E11387.
127. Katakowski M, Buller B, Wang X, et al., Functional microRNA is transferred between glioma cells. Cancer Res 2010; 70: 8259-63.
128. Kizana E, Cingolani E, Marban E., Non-cell-autonomous effects of vector-expressed regulatory RNAs in mammalian heart cells. Gene Ther 2009; 16: 1163-8.
129. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, et al., Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2011; 2: 282.
130. Fabian MR, Sonenberg N., The mechanics of miRNA-mediated gene silencing: A look under the hood of miRISC. Nat Struct Mol Biol 2012; 19: 586-93.
131. Eiring AM, Harb JG, Neviani P, et al., miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 2010; 140: 652-65.
132. Fabbri M, Paone A, Calore F, et al., MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Nl Acad Sci USA 2012; 109: E2110-6.
133. Ghasemi R, Grassadonia A, Tinari N, et al., Tumor-derived microvesicles: The metastasomes. Med Hypotheses 2013; 80: 75-82.